Doug Drysdale On How CYB-003 Is Better Than Psilocybin
Interview with Doug Drysdale, CEO of Cybin
Psychedelic Spotlight Podcast · Global Trac Solutions Inc., Psychedelic Spotlight, The Psychedelic Investor, James Hallifax, Doug Drysdale, Cybin
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues. The conversation then pivots to what Cybin sees as the main issues with psilocybin: its long duration of effect, long period before onset action, and the variability in effects from person to person.
*Learn more about Cybin by visiting their website: Cybin.com
*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!
*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com